Sim, Kim Lan; Perry, David (1 September 1995). "Swainsonine production by Metarhizium anisopliae determined by means of an enzymatic assay". Mycological Research. 99 (9): 1078–1082. doi:10.1016/S0953-7562(09)80776-4.
Gardner, DR; Cook, D (2016). "Analysis of Swainsonine and Swainsonine N-Oxide as Trimethylsilyl Derivatives by Liquid Chromatography-Mass Spectrometry and Their Relative Occurrence in Plants Toxic to Livestock". J Agric Food Chem. 64 (31): 6156–62. doi:10.1021/acs.jafc.6b02390. PMID27436221.
Cook D, Beaulieu WT, Mott IW, Riet-Correa F, Gardner DR, Grum D, Pfister JA, Clay K, Marcolongo-Pereira C (April 2013). "Production of the alkaloid swainsonine by a fungal endosymbiont of the Ascomycete order Chaetothyriales in the host Ipomoea carnea". Journal of Agricultural and Food Chemistry. 61 (16): 3797–803. doi:10.1021/jf4008423. PMID23547913.
Harris, Constance M.; Bruce C. Campbell; Russell J. Molyneux; Thomas M. Harris (1988). "Biosynthesis of swainsonine in the diablo locoweed (Astragalus oxyphyrus)". Tetrahedron Letters. 29 (38): 4815–4818. doi:10.1016/S0040-4039(00)80616-4.
Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z, Yang Q (May 2009). "Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo". Phytomedicine. 16 (11): 1070–4. doi:10.1016/j.phymed.2009.02.012. PMID19427771.
Sun JY, Zhu MZ, Wang SW, Miao S, Xie YH, Wang JB (May 2007). "Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine". Phytomedicine. 14 (5): 353–9. doi:10.1016/j.phymed.2006.08.003. PMID17097281.
Shaheen PE, Stadler W, Elson P, Knox J, Winquist E, Bukowski RM (December 2005). "Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma". Investigational New Drugs. 23 (6): 577–81. doi:10.1007/s10637-005-0793-z. PMID16034517. S2CID33471927.
Oredipe OA, Furbert-Harris PM, Laniyan I, Griffin WM, Sridhar R (October 2003). "Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine". International Immunopharmacology. 3 (10–11): 1537–47. doi:10.1016/S1567-5769(03)00186-3. PMID12946451.
Sladek, V.; Kóňa, J.; Tokiwa, H. (2017). "In silico analysis of interaction pattern switching in ligand⋯receptor binding in Golgi α-mannosidase II induced by the protonated states of inhibitors". Physical Chemistry Chemical Physics. 19 (19): 12527–12537. Bibcode:2017PCCP...1912527S. doi:10.1039/c7cp01200d. PMID28470253.
Sladek, V.; Kóňa, J.; Tokiwa, H. (2017). "In silico analysis of interaction pattern switching in ligand⋯receptor binding in Golgi α-mannosidase II induced by the protonated states of inhibitors". Physical Chemistry Chemical Physics. 19 (19): 12527–12537. Bibcode:2017PCCP...1912527S. doi:10.1039/c7cp01200d. PMID28470253.
Gardner, DR; Cook, D (2016). "Analysis of Swainsonine and Swainsonine N-Oxide as Trimethylsilyl Derivatives by Liquid Chromatography-Mass Spectrometry and Their Relative Occurrence in Plants Toxic to Livestock". J Agric Food Chem. 64 (31): 6156–62. doi:10.1021/acs.jafc.6b02390. PMID27436221.
Cook D, Beaulieu WT, Mott IW, Riet-Correa F, Gardner DR, Grum D, Pfister JA, Clay K, Marcolongo-Pereira C (April 2013). "Production of the alkaloid swainsonine by a fungal endosymbiont of the Ascomycete order Chaetothyriales in the host Ipomoea carnea". Journal of Agricultural and Food Chemistry. 61 (16): 3797–803. doi:10.1021/jf4008423. PMID23547913.
Panter KE, James LF, Stegelmeier BL, Ralphs MH, Pfister JA (February 1999). "Locoweeds: effects on reproduction in livestock". Journal of Natural Toxins. 8 (1): 53–62. PMID10091128.
Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z, Yang Q (May 2009). "Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo". Phytomedicine. 16 (11): 1070–4. doi:10.1016/j.phymed.2009.02.012. PMID19427771.
Sun JY, Zhu MZ, Wang SW, Miao S, Xie YH, Wang JB (May 2007). "Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine". Phytomedicine. 14 (5): 353–9. doi:10.1016/j.phymed.2006.08.003. PMID17097281.
Shaheen PE, Stadler W, Elson P, Knox J, Winquist E, Bukowski RM (December 2005). "Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma". Investigational New Drugs. 23 (6): 577–81. doi:10.1007/s10637-005-0793-z. PMID16034517. S2CID33471927.
Das PC, Roberts JD, White SL, Olden K (1995). "Activation of resident tissue-specific macrophages by swainsonine". Oncology Research. 7 (9): 425–33. PMID8835286.
Oredipe OA, Furbert-Harris PM, Laniyan I, Green WR, Griffin WM, Sridhar R (November 2003). "Mice primed with swainsonine are protected against doxorubicin-induced lethality". Cellular and Molecular Biology (Noisy-le-Grand, France). 49 (7): 1089–99. PMID14682391.
Oredipe OA, Furbert-Harris PM, Laniyan I, Green WR, Griffin WM, Sridhar R (November 2003). "Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice". Cellular and Molecular Biology (Noisy-le-Grand, France). 49 (7): 1037–48. PMID14682385.
Oredipe OA, Furbert-Harris PM, Laniyan I, Griffin WM, Sridhar R (October 2003). "Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine". International Immunopharmacology. 3 (10–11): 1537–47. doi:10.1016/S1567-5769(03)00186-3. PMID12946451.
Sladek, V.; Kóňa, J.; Tokiwa, H. (2017). "In silico analysis of interaction pattern switching in ligand⋯receptor binding in Golgi α-mannosidase II induced by the protonated states of inhibitors". Physical Chemistry Chemical Physics. 19 (19): 12527–12537. Bibcode:2017PCCP...1912527S. doi:10.1039/c7cp01200d. PMID28470253.
Shaheen PE, Stadler W, Elson P, Knox J, Winquist E, Bukowski RM (December 2005). "Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma". Investigational New Drugs. 23 (6): 577–81. doi:10.1007/s10637-005-0793-z. PMID16034517. S2CID33471927.